The journey of a **liquid biopsy** test, from a simple blood draw to guiding a patient's targeted therapy, is heavily governed by stringent regulatory pathways and constrained by persistent cost-effectiveness challenges. Regulatory scrutiny, particularly from bodies like the FDA in the US, is crucial because liquid biopsy results directly influence life-altering treatment decisions. The path to...
booking
Youplay
NR shop
thai
French
Spanish
Portuguese
Italiano
Romaian
Portuguese (Brazil)
china